FibroGen Investor Relations Material
Latest events
Q2 2025
FibroGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from FibroGen Inc
Access all reports
FibroGen Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious unmet medical needs, particularly in areas like fibrosis, oncology, and anemia. The company’s lead products target conditions such as chronic kidney disease-related anemia and idiopathic pulmonary fibrosis. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for FibroGen Inc
Q3 2024
FibroGen Inc
Q4 2024
FibroGen Inc
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
FGEN
Country
🇺🇸 United States